Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Did Lilly Overcome US Price Pressures In Last Quarter? Investors Await Answer
Jan 28 2020
•
By
Joseph Haas
Lilly is more reliant on sales from Medicare Part D than its peers
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business